Gastric Balloon

Introduction to a Nonsurgical Weight Loss Tool

Presenting a noninvasive solution to weight loss, the gastric balloon treatment emerges as a viable option for individuals unwilling to undergo surgery. According to experts, approximately 114 million people in the United States could benefit from some form of weight loss program, with 16 million potentially qualifying for bariatric surgery.

The Challenge of Obesity: A Chronic Disease

Obesity, recognized as a chronic disease, exposes individuals to various health risks, including heart disease, high blood pressure, diabetes, and osteoarthritis. The gastric balloon treatment offers a safe alternative for specific patients who prefer non-surgical interventions.

Patient Eligibility and Considerations

While the gastric balloon procedure provides a promising avenue for weight loss, it may not be suitable for everyone. Individuals with hiatal hernias, uncontrolled reflux, those on blood thinners, or individuals with a history of stomach surgery may not be the ideal candidates.

FDA Approval and Current Criteria

The Food and Drug Administration (FDA) granted approval for the gastric balloon procedure in the United States in 2015. Presently, this treatment is available for individuals with a Body Mass Index (BMI) of at least 30, subject to successful health screening. Notably, those with class III obesity, who may qualify for bariatric surgery, may opt for the gastric balloon due to its relatively lower risks. Additionally, individuals for whom surgery poses a health risk can use the balloon as a preliminary step to drop enough weight, eventually making them eligible for surgery.

In summary, the gastric balloon treatment stands as an FDA-approved, noninvasive approach to weight loss, catering to a diverse range of individuals navigating the challenges of obesity.